This is biochemist Katalin Karikó’s second time on the STATUS List, and with good reason: Her pioneering research on mRNA technology that led to the speedy development of Covid-19 vaccines, in partnership with immunologist Drew Weissman, won the Nobel Prize in medicine or physiology this past fall. It was the latest in a series of awards and recognition that Karikó has received after persisting through decades of struggle to get adequate funding, and her story has brought fresh attention to the academia’s problem of chronically ignoring and underestimating promising scientists, particularly women and others from marginalized backgrounds. But as Karikó noted at a Nobel press briefing, for her, the recent wave of recognition is beside the point. “We are not working for any kind of award,” Karikó said. “The importance was to have a product which is helpful.” Those curious to learn more about her career journey from an impoverished Hungarian family to co-creator of a revolutionary technology can dive into her recently published memoir, “Breaking Through.”
More in Medicine
Medicine
Foluso Fakorede
CEO, Cardiovascular Solutions of Central Mississippi and Fusion Vascular
Medicine
Laurie Glimcher
President and CEO, Dana-Farber Cancer Institute
Medicine
Alex Keuroghlian
Director, The National LGBTQIA+ Health Education Center
Medicine
Grace Lee
Chief quality officer, Stanford Medicine Children’s Health
Medicine
Aletha Maybank
Chief health equity officer and senior vice president, American Medical Association
Medicine
Stuart Orkin
David G. Nathan Distinguished Professor, Harvard Medical School; investigator, HHMI
Medicine
Steven Rosenberg
Chief, surgery branch, National Cancer Institute
Medicine
Melissa A. Simon
OB-GYN and professor, Northwestern Medicine
Medicine
Krystal Tsosie
Assistant professor of life sciences, Arizona State University
Medicine
Drew Weissman
Director of vaccine research, infectious diseases division, University of Pennsylvania
Fifty influential people shaping the future of health and life sciences across biotech, medicine, health care, policy, and health tech
View the List